Development of Magnetic Resonance (MR) Simulation for Treatment Planning
Sponsor
AHS Cancer Control Alberta (Other)
Overall Status
Completed
CT.gov ID
NCT00314496
Collaborator
Cross Cancer Institute (Other)
10
1
50
0.2
Study Details
Study Description
Brief Summary
Retrospectively have access to MR images of patients to develop software that:
-
segment images
-
convert MR values to electron density and then
-
entered into a dose calculation system
The project involves software development of data that is already available. No intervention is made at this point.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
10 participants
Time Perspective:
Retrospective
Official Title:
Development of MR Simulation for Treatment Planning
Study Start Date
:
Sep 1, 2005
Actual Primary Completion Date
:
Nov 1, 2009
Actual Study Completion Date
:
Nov 1, 2009
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Subject 18 years of age and older
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Cross Cancer Institute | Edmonton | Alberta | Canada | T6G 1Z2 |
Sponsors and Collaborators
- AHS Cancer Control Alberta
- Cross Cancer Institute
Investigators
- Principal Investigator: Gino Fallone, PhD, AHS Cancer Control Alberta
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
AHS Cancer Control Alberta
ClinicalTrials.gov Identifier:
NCT00314496
Other Study ID Numbers:
- EX-0004
First Posted:
Apr 14, 2006
Last Update Posted:
Feb 25, 2016
Last Verified:
Jan 1, 2012